Shelly Lo
  • Associate Professor
  • Program Director, Hospice
  • Hematology/Oncology
Breast Cancer, Chemoprevention of Breast Cancer, Colorectal Cancer, Gastrointestinal Cancers, General Oncology, GIST, Genetic Counseling, Pancreatic Cancer, Stomach Cancer
Board Certifications
  • Hematology - Subspecialty Cert: AM Board of Internal Medicine
  • Hospice and Palliative Medicine - Subspecialty: AM Board of Internal Medicine
  • Medical Oncology - Subspecialty Cert: AM Board of Internal Medicine

The tolerance of gastrointestinal organs to stereotactic body radiation therapy: what do we know so far?Thomas,T. O.; Hasan,S.; Small,W.,Jr; Herman,J. M.; Lock,M.; Kim,E. Y.; Mayr,N. A.; Teh,B. S.; Lo,S. S.Journal of gastrointestinal oncology 2014 ;5(3):236-246

Extrapulmonary small cell carcinoma of the anal canal: a case report and review of the literatureEberhardt,J. M.; Brown,K.; Lo,S.; Nagda,S.; Yong,S.Case reports in medicine 2012 ;2012( ):341432

Differentially expressed genes and pathways induced by organophosphates in human neuroblastoma cellsLi,T.; Zhao,H.; Hung,G. C.; Han,J.; Tsai,S.; Li,B.; Zhang,J.; Puri,R. K.; Lo,S. C.Experimental biology and medicine (Maywood, N.J.) 2012 ;237(12):1413-1423

Impact of Multigene Assays in Early Stage Breast CancerLo,S. S.; Albain,K. S.Oncologist 2011 ;16(11):1482-1483

Roadmap for harmonization of clinical laboratory measurement proceduresGreg Miller,W.; Myers,G. L.; Lou Gantzer,M.; Kahn,S. E.; Schonbrunner,E. R.; Thienpont,L. M.; Bunk,D. M.; Christenson,R. H.; Eckfeldt,J. H.; Lo,S. F.; Nubling,C. M.; Sturgeon,C. M.Clinical chemistry 2011 ;57(8):1108-1117

Residual disease after neoadjuvant chemotherapy for breast cancerMorris,G. J.; Robinson,P. A.; Lo,S.; Samuel,T. A.; Sheikh,A. A.; Jordan,W. E.,3rd; Thomas,L. C.; Kiel,K.; Peters,C. A.Seminars in oncology 2010 ;37(1):1-10

Inhibition of Notch signaling reduces the stem-like population of breast cancer cells and prevents mammosphere formation.Grudzien,P.; Lo,S.; Albain,K. S.; Robinson,P.; Rajan,P.; Strack,P. R.; Golde,T. E.; Miele,L.; Foreman,K. E.Anticancer Research 2010 ;30(10):3853-3867

A phase II study of weekly docetaxel in combination with capecitabine in advanced gastric and gastroesophageal adenocarcinomasLo,S. S.; Khorana,A. A.; Javle,M.; Simon,S.; Kiefer,G.; Rajasenan,K.; Wang,H.; Hantel,A.; Shayne,M.; Hwang,J.; Schmotzer,A.; Ramanathan,R. K.ONCOLOGY 2010 ;78(2):125-129

Prospective multicenter study of the impact of the 21-gene recurrence score assay on medical oncologist and patient adjuvant breast cancer treatment selection.Lo,S. S.; Mumby,P. B.; Norton,J.; Rychlik,K.; Smerage,J.; Kash,J.; Chew,H. K.; Gaynor,E. R.; Hayes,D. F.; Epstein,A.; Albain,K. S.Journal of Clinical Oncology 2010 ;28(10):1671-1676

Endocrine Therapy with Selective Estrogen Receptor Modulators (SERMs) and Aromatase Inhibitors in the Prevention and Adjuvant Therapy SettingsLo,S. S.; Pritchard,K. I.; Robinson,P.; Albain,K. S.Cancer treatment and research 2009 ;147( ):1-29

Estimating the changes in energy flux that characterize the rise in obesity prevalence.Swinburn,B. A.; Sacks,G.; Lo,S. K.; Westerterp,K. R.; Rush,E. C.; Rosenbaum,M.; Luke,A.; Schoeller,D. A.; DeLany,J. P.; Butte,N. F.; Ravussin,E.American Journal of Clinical Nutrition 2009 ;89(6):1723-1728

Long-term follow-up of 111In-capromab pendetide (ProstaScint) scan as pretreatment assessment in patients who undergo salvage radiotherapy for rising prostate-specific antigen after radical prostatectomy for prostate cancer.Nagda,S. N.; Mohideen,N.; Lo,S. S.; Khan,U.; Dillehay,G.; Wagner,R.; Campbell,S.; Flanigan,R. C.International journal of radiation oncology, biology, physics 2007 ;67(3):834-840

Impact of tumor volume-directed involved field radiation therapy integrated in the management of recurrent ovarian cancer.Albuquerque,K. V.; Singla,R.; Potkul,R. K.; Smith,D. M.; Creech,S.; Lo,S.; Emami,B.Gynecologic oncology 2005 ;96(3):701-704

Unusual thoracic problems in patients with malignancies: case 1. Neuroblastoma presenting with intracardiac tumor thrombus.Nagda,S. N.; Lo,S. S.; Melian,E.; Manera,R.; Emami,B.Journal of Clinical Oncology 2005 ;23(12):2856-2857

Thapsigargin modulates osteoclastogenesis through the regulation of RANKL-induced signaling pathways and reactive oxygen species productionYip,K. H.; Zheng,M. H.; Steer,J. H.; Giardina,T. M.; Han,R.; Lo,S. Z.; Bakker,A. J.; Cassady,A. I.; Joyce,D. A.; Xu,J.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2005 ;20(8):1462-1471

Neoadjuvant therapy: an emerging concept in oncologyTanvetyanon,T.; Clark,J. I.; Campbell,S. C.; Lo,S. S.Southern medical journal 2005 ;98(3):338-344

Endocrine prevention of breast cancer using selective oestrogen receptor modulators (SORMs)Lo,S. S.; Vogel,V. G.Best practice & research.Clinical endocrinology & metabolism 2004 ;18(1):97-111

Multimodality treatment in a case of primary cardiac lymphomaLo,S. S.; Yeager,A. M.; Peel,R. L.; Katz,W. E.; Ramanathan,R. K.Clinical lymphoma 2003 ;4(2):112-114

Medical School
  • SUNY Upstate Medical University College of Medicine
  • Albany Medical Center Hospital, Internal Medicine & Pediatrics
  • University of Pittsburgh Medical Center, Hematology/Oncology
  • Mount Sinai Medical Center, Hematology/Oncology
  • Bicycling
  • Cooking
  • Travel